Urology
About Urology Surgical Research
Can steroid use during certain periods of development impact on the likeliehood of a patient developing benign and malignant prostate disease? What are the potential uses of post operative intravesical (bladder treatment via a catheter) chemotherapy for superficial transitional cell carcinoma (TCC) and tolerability of certain stent types? These are some of the questions our team are asking to help improve the outcomes of urological surgery.
Meet the team
Unit Heads
- Mr Scott Donnellan | +61 3 9928 8643
- Prof Mark Frydenberg
Adjunct Clinical Lecturer
Location